Skip to main content

Preparation of Anti-Sperm Protein 17 Immunomagnetic Nanoparticles for Targeting Cell

Buy Article:

$113.00 plus tax (Refund Policy)

Abstract:

Poly(ethylene glycol) was functionalized with carboxyl groups by esterification with succinic anhydride in the media of dioxane and pyridine as catalyst. Maghemite nanoparticles were synthesized by chemical coprecipitation and coated with carboxylated poly(ethylene glycol) to improve their biocompatibility. And the properties were characterized using Fourier transform infrared spectroscopy, Transmission electronic microscopy, X-ray diffraction, Zeta potential analyzer and Vibrating sample magnetometer. The immunomagnetic nanoparticles were obtained by grafting anti-sperm protein 17 monoclonal antibody onto the surface of carboxylated poly(ethylene glycol) coated maghemite nanoparticles by covalent bonds. After incubated with human sperm protein 17 gene transfected ovarian cancer HO8910 cells, the immunomagnetic nanoparticles were targeted successfully to the positive cells and no obviously non-specific adsorption occured. It is of significance to target to the cell successfully for diagnosis and therapy of ovarian carcinoma such as magnetic resonance imaging and magnetic hyperthermia.

Keywords: CARBOXYLATED POLY(ETHYLENE GLYCOL); IMMUNOMAGNETIC NANOPARTICLES; OVARIAN CANCER; SPERM PROTEIN; TARGET

Document Type: Research Article

DOI: https://doi.org/10.1166/jnn.2008.084

Publication date: 2008-05-01

More about this publication?
  • Journal for Nanoscience and Nanotechnology (JNN) is an international and multidisciplinary peer-reviewed journal with a wide-ranging coverage, consolidating research activities in all areas of nanoscience and nanotechnology into a single and unique reference source. JNN is the first cross-disciplinary journal to publish original full research articles, rapid communications of important new scientific and technological findings, timely state-of-the-art reviews with author's photo and short biography, and current research news encompassing the fundamental and applied research in all disciplines of science, engineering and medicine.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free ContentFree content
  • Partial Free ContentPartial Free content
  • New ContentNew content
  • Open Access ContentOpen access content
  • Partial Open Access ContentPartial Open access content
  • Subscribed ContentSubscribed content
  • Partial Subscribed ContentPartial Subscribed content
  • Free Trial ContentFree trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more